VitroGel® MMP High Concentration
VitroGel® MMP High Concentration is a tunable, xeno-free (animal origin-free) hydrogel system modified with matrix metalloproteinase-sensitive peptides. The enzyme-sensitive hydrogel can be degraded by several MMPs (MMP1, MMP2, MMP3, MMP9, and MMP13) and supports various biological activities, including cell proliferation, migration (adhesion/dispersion), differentiation, angiogenesis, and apoptosis. VitroGel MMP High Concentration comes with VitroGel Dilution Solution to adjust the final hydrogel strength from 10 to 4000 Pa.
VitroGel® High Concentration hydrogels are our xeno-free, tunable hydrogels for researchers wanting full control to manipulate the biophysical and biological properties of the cell culture environment. The tunability of the hydrogel enables the creation of an optimized environment for cell growth. The hydrogel system has a neutral pH, is transparent, permeable, and compatible with different imaging systems. The solution transforms into a hydrogel matrix by simply mixing with the cell culture medium. No cross-linking agent is required. Cells cultured in this system can be easily harvested with our VitroGel® Cell Recovery Solution. The hydrogel can also be tuned to be injectable for in vivo studies.
From 3D cell culture, 2D cell coating to animal injection, VitroGel® makes it possible to bridge the in vitro and in vivo studies with the same platform system.
Mix & Match – 3D Cell Culture Your WAY!
Unique to VitroGel® High Concentration hydrogels is the ability to customize a multi-functional hydrogel by blending different types of VitroGel® . VitroGel® MMP can be “mix & matched” with other versions of VitroGel, such as VitroGel® RGD, VitroGel® YIGSR, VitroGel® IKVAV, and VitroGel® COL to create a customized multi-functional hydrogel. Using this flexible and powerful hydrogel system, scientists can tailor their 3D culture micro-environment for different applications.
Specifications
| Contents | VitroGel® MMP High Concentration, 3 mL VitroGel® Dilution Solution, 50 mL |
| Hydrogel Formulation | Xeno-free tunable hydrogel modified with matrix metalloproteinases sensitive peptide. |
| Use | MMP sensitive biodegradable hydrogel. |
| Mix & Match | Can be blended with other versions of VitroGel concentrated hydrogels to create a custom multi-functional matrix. |
| Operation | Room temperature |
| Hydrogel Strength | 10 to 4,000 Pa of G’ depending on dilution ratio. Dilute with VitroGel Dilution Solution (TYPE 1 or TYPE 2) for different concentrations. |
| pH | Neutral |
| Color | Transparent |
| Cell Harvesting | VitroGel Organoid Recovery Solution 5-15 min cell recovery |
| Injectable | Injectable hydrogel |
| Storage | Store at 2-8°C. Ships at ambient temperature |
| Number of Uses | Dilution ratio: 1:2 = 225 uses at 50 µL per well 1:3 = 300 uses at 50 µL per well 1:5 = 450 uses at 50 µL per well |
3D Cell Culture Process in 20 Minutes
VitroGel® High Concentration hydrogels are easy to use. There is no cross-linking agent required. Work confidently at room temperature.
Tunable Hydrogel Strength
Simply diluting the hydrogel controls the gel strength.
Video Protocols & Demonstrations
Data and References
Cell Type Behavior Reference Table – VitroGel® MMP
Multiple examples of immobilized, conjugated MMP substrate peptides in hydrogels in different tissues and cell type. MMPs’ activity is critical in remodeling the extracellular matrix. Hydrogels with MMP substrate peptides incorporated allow for the study of MMP activity in multiple cell types.
| Tissue/Organ Type | Cell Type | Behavior |
|---|---|---|
| Breast | Mammary gland MCF10A | Increased MMP activity in response to TGF-ß1 |
| Cancer/tumor | Breast MDA-MB-231 | Enhanced cell invasion |
| Glioma U87 | Support cell growth, spreading, and migration | |
| Melanoma WM239A | Promoted cell invasion | |
| Connective tissue | Human foreskin fibroblasts | Increased radial cell migration |
| Human foreskin fibroblasts | Increased cell invasion and substrata degradation | |
| Stem cells | Human mesenchymal stem cells | Increased cell differentiation marker expression |
| Human mesenchymal stem cells | Promoted neuronal differentiation and neurite outgrowth | |
| Human mesenchymal stem cells | Increased cell spreading, traction forces, and differentiation | |
| Mouse mesenchymal stem cells | Increased cell spreading and migration | |
| Vascular | Human umbilical vein endothelial cell | Promoted cell adhesion, migration, and survival |
| Human umbilical vein endothelial and umbilical artery smooth muscle cells | Increased aggregate cell invasion toward gradient of peptide | |
| Human umbilical vein endothelial cells | Increased cell invasion |
| TISSUE/ORGAN TYPE | CELL TYPE | READY TO USE | HIGH CONCENTRATION | BEHAVIOR | |
|---|---|---|---|---|---|
| Beta Cell | BL5 human beta cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D VitroGel® MMP | Enhance spheroids formation | |
| Beta TC3 cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cellular interactions | ||
| Bone | Bone marrow stromal cells (rat) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP | Osteogensic differentiation Cell attachment and osteoblast differentiation Cell proliferation cell viability and cellular networking | |
| Osteoblasts (rat) | VitroGel® MSC VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell attachment and spreading | ||
| Bone marrow stromal cells (bovine) | VitroGel® MSC VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell spreading and osteocalcin expression | ||
| Breast | Mammary gland MCF10A | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitrolGel RGD VitroGel® COL VitroGel® MMP | Spheroid formation MMP activity in response to TGF-B1 | |
| Mammary epithelium (mouse) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell invasion and dissemination | ||
| Cancer/Tumor | Human colorectal carcinoma HCT 116 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation cell survival and intercellular networking | |
| Huaman colon carcinoma HCT-8 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Glioma U87-MG | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® MMP VitroGel® COL | Cell spreading and acting stress fiber assembly cell proliferation spreading and migration Cell migration dependent on mechancial force Cell proliferation and cell matrix interaction | ||
| Gliobastoma SF 268 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitrolGel RGD | Cell proliferation and cell matrix interaction | ||
| Gliobastoma SF 295 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Glioblastoma SNB75 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Glioblastoma U-251 MG | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Prostate PC3 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® COL VitroGel® IKVAV VitroGel® RGD VitroGel® MMP | Cell proliferation reduced MMP release invasion migration and spheroid metabolic activity. | ||
| Prostate LNCaP | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell attachment proliferation and prostate specific antigen release | ||
| Prostate CRPC | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and invasion | ||
| Prostate DU145 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and invasion | ||
| Melanoma B16F10 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® COL VitroGel® YIGSR | Cell migration invasion MMP release cell attachment and spreading | ||
| Breast MDA-MB-231 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® MMP VitroGel® 3D | Cell invasion spreading proliferation division migration and cluster growth | ||
| Fibrosarcoma HT1080 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell infiltration attachment | ||
| Breast T47D | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® COL VitroGel® 3D VitroGel® RGD VitroGel® MMP | Force dependent tubule formation cell cluster growth spheroid formation and proliferation | ||
| Breast 4T1 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation | ||
| Breast CTC | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D VitroGel® RGD | Cell proliferation | ||
| Breast E0771 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation spheroid formation | ||
| Brest AU-565 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation cell matrix interactions | ||
| Epithelial ovarian OV-MZ-6 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Spheroid formation and proliferation | ||
| Epithelial ovarian SKOV-3 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Spheroid formation and proliferation | ||
| Glioma U373-MG | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP | Cell adhesion invasion and migration | ||
| Rhabdomyosarcoma (human) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® YIGSR | Cell attachment and spreading | ||
| Melanoma SK-MEL-28 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® IKVAV | Cell adhesion and proliferation | ||
| Melanoma K-1735 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® IKVAV | Cell invasion | ||
| Melanoma A2058 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® IKVAV | Collagenolytic activity | ||
| Brainstem glioma DIPG | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP | Cell proliferation and survival | ||
| Hela Cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D VitroGel® RGD VitroGel® MMP | Cell proliferation | ||
| Colorectal adenocarcinoma DLD-1 cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Giloma LRM55 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® IKVAV VitroGel® MMP | Cell attachment | ||
| Melanoma WM 239A | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP | Cell invasion | ||
| Melanoma Cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Insulinoma ins-1 (Rat) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Biphasic synovial sarcoma SYO-1 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation cell matrix interation and cell survival | ||
| Fuji Cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and cell matrix interaction | ||
| Chordoma Cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D | Cell proliferation | ||
| Bone OSA 1777 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Spheroid and cluster formation | ||
| Glioma RuGli | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® COL | Integrin dependent cell adhesion | ||
| Breast Cancer MCF-7 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP VitroGel® 3D | Cell proliferation intercellular connections morphological changes MMP expression and angiogenesis | ||
| Liver carcinoma HepG2 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell viability growth drug resistance proliferation and cellular matrix interaction | ||
| Human pancreatic cancer PANC-1 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP | Cell proliferation and cellular interactions | ||
| Primary breast (human) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP | Cell invasion migration and dissemination | ||
| Ovarian carcinoma OVCAR-3 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® MMP | Cell proliferation cell matrix interactions | ||
| Ovarian OVCA429 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® MMP VitroGel® COL | MMP dependent cell invasion | ||
| Human Osteosarcoma KHOS | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® 3D | Cell proliferation and spheroids formation | ||
| Human Osteosarcoma U2OS | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® 3D | Cell proliferation and spheroids formation | ||
| Human fibroblast-like synoviocytes (FLS) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D | Cell proliferation and inflammatory responses | ||
| Human Liposarcoma 94T778 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D | Cell proliferation and spheroids formation | ||
| Human diffuse large B-cell lymphoma (DLBLC) SUDHL-10 | VitroGel® Hydrogel Matrix | Cell viability growth drug resistance proliferation and cellular matrix interaction | |||
| Priess human lymphoblastoid cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D | Enhance spheroids and cluster formation and promote cell viability. | ||
| Cartilage | Chondrocytes (bovine) | VitroGel® MSC VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell viability and proliferation | |
| Chondrocytes (human) | VitroGel® MSC VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell viability and proliferation | ||
| Connective Tissue | Dermal Fibroblasts (human) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell viability and spreading | |
| Fibroblasts NIH3T3 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Directional cell migration toward gradient and cell spreading dependent on substrata rigidity | ||
| Foreskin fibroblasts (human) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® YIGSR VitroGel® MMP | Cell spreading substrata degradation and cell invasion | ||
| Skin fibroblasts (skin) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® IKVAV | Cell adhesion | ||
| Epidermal keratinocytes | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell viability | ||
| Epithelial Cells | Mouse ovarian follicle cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | 3D cell culture using ES-hydrogel can enhance vitro follicle culture by considering the permeability and stiffness of the gel. | |
| Human Nthy-ori 3-1 cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D | Enhance spheroids and cluster formation and promote cell viability. | ||
| A549 cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Enhance cell proliferation and cell matrix interactions. | ||
| MCF-12A | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Enhance cell proliferation and cell matrix interactions. | ||
| Immortalized bronchial epithelial cells HBEC-KRAS | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® 3D | Cell proliferation | ||
| Eye | Corneal endothelial B4G12 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit VitroGel® Angiogenesis Assay | VitroGel® RGD VitroGel® Angiogenesis Assay HC kit | Cell attachment and spreading | |
| Retinal ganglion cells (xenopus) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Neurite outgrowth | ||
| Immune Cells | CD8 + T cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D | Enhance spheroids and cluster formation and promote cell viability. | |
| Kidney | Human embryonic kidney HEK293 | VitroGel® Hydrogel Matrix VitroGel® HEK293 VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | 3D spheroids formation | |
| Madin-Darby Canine Kidney | VitroGel® Hydrogel Matrix VitroGel® HEK293 VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® MMP | Epithelial cysts formation | ||
| Podocytes (human) | VitroGel® Hydrogel Matrix VitroGel® HEK293 VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Glomerular capillary formation | ||
| glomerular endothelial cells (human) | VitroGel® Hydrogel Matrix VitroGel® HEK293 VitroGel® ORGANOID Disovery Kit VitroGel® Angiogenesis Assay | VitroGel® RGD VitroGel® Angiogenesis Assay HC kit | Glomerular capillary formation | ||
| Liver | Hepatocytes (human) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Filopodia formation and synthesis of albumin and cell attachment | |
| Hepatocytes (mouse rat swine) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® MMP | Cell viability spearding Albumin secretion | ||
| Lung | Alveolar basal epithelial A549 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell attachment | |
| Alveolar epithelial RLE-6TN | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell attachment and mesenchymal differentiation | ||
| Pulmonary fibroblasts LL2 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® IKVAV | Cell adhesion | ||
| HFL1 lung fibroblasts CCL153 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell proliferation and spindle morphology | ||
| Lung cancer associated fibroblasts (human) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Substrata contractility | ||
| Lung fibroblasts MCR-5 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | NGF-mediated substrata contraction | ||
| Muscle | Myoblasts C2C12 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell proliferation differentiation attachment myofibril formation myotube formation and integrin dependent cell adhesion | |
| Skeletal myoblasts (mouse) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD | Cell attachment proliferation and myofibril formation | ||
| Myoblasts (human) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell adhesion alignment along fiber and myotube formation | ||
| Myoblasts C25Cl48 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL | Cell proliferation differentiation and myotube formation | ||
| Neural | Dorsal root ganglion (chick) | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit VitroGel® NEURON | VitroGel® RGD VitroGel® COL | Neurite formation and force dependent neurite outgrowth | |
| Neural PC12 | VitroGel® Hydrogel Matrix | VitroGel® RGD VitroGel® IKVAV | Neurite outgrowth | ||
| Neural stem cell/ progenitor cell (rat) | VitroGel® STEM VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® IKVAV | Cell viability attachment and differentiation | ||
| Neural stem cell/ progenitor cell (human) | VitroGel® STEM VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® IKVAV VitroGel® COL | Cell viability attachment and differentiation | ||
| Schwann cells (rat) | VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD | Cell attachment and migration | ||
| Neural stem cell/ progenitor cell (mouse) | VitroGel® STEM VitroGel® NEURON | VitroGel® RGD VitroGel® IKVAV | Cell adhesion and differentiation | ||
| Cortical astrocytes (rat) | VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® IKVAV | Cell adhesion | ||
| Spiral ganglion neurons (mouse) | VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® IKVAV | Neurite outgrowth | ||
| Motor neurons (human) | VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® COL VitroGel® IKVAV | Force dependent neurite outgrowth | ||
| Forebrain neurons (human) | VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® COL VitroGel® IKVAV | Force dependent neurite outgrowth | ||
| Cortical neurons (rat) | VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® COL VitroGel® IKVAV | Neuronal viability and neurite outgrowth | ||
| Dorsal root ganglion (rat) | VitroGel® Hydrogel Matrix VitroGel® NEURON | VitroGel® RGD VitroGel® COL VitroGel® IKVAV | Neurite outgrowth | ||
| Red Blood Cells | Red Blood Cells | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® 3D | Enhance Spheroids and cluster formation and promote cell viability | |
| Pancreas | B-cells MIN6 | VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® IKVAV | Reduced apoptosis and increased insulin release | |
| Stem Cells | Mesenchymal stem cells (human) | VitroGel® MSC | VitroGel® RGD VitroGel® COL VitroGel® IKVAV VitroGel® MMP | Cell viability proliferation differentiation neuronal differntiation neurite outgrowth attachment spreading viability and osteoblast differentiation | |
| Mesenchymal stem cells (mouse) | VitroGel® MSC | VitroGel® RGD VitroGel® MMP | Cell spreading and migration | ||
| Mesenchymal stem cells (rat) | VitroGel® MSC | VitroGel® RGD | Cell adhesion and spreading | ||
| Embryonic stem cells (mouse) | VitroGel® STEM VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® COL VitroGel® YIGSR | Endothelial cell differentiation neuronal differentiation and neurite outgrowth | ||
| Induced pluripotent stem cells (human) | VitroGel® STEM VitroGel® ORGANOID Disovery Kit | VitroGel® RGD VitroGel® YIGSR VitroGel® IKVAV | Cell viability | ||
| Human stem cells from apical papilla SCAP | VitroGel® STEM | VitroGel® RGD | Cell viability | ||
| Hematopoietic Stem Cells | VitroGel® STEM | Cell viability | |||
| Adipose derived stem cells (human) | VitroGel® MSC | VitroGel® RGD VitroGel® 3D VitroGel® IKVAV | Cell viability cell attachment | ||
| Vascular/cardiac | Umbilical vein endothelial cells | VitroGel® Angiogenesis Assay VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® Angiogenesis Assay HC kit | Cell attachment proliferation migration angiogenesis gene expression changes migratory cell infiltration cell survival and VEGF dependent migration | |
| Neonatal cardiac (rat) | VitroGel® Angiogenesis Assay VitroGel® Hydrogel Matrix VitroGel® ORGANOID Disovery Kit | VitroGel® Angiogenesis Assay HC kit | Cell attachment tissue regeneration and attachment similar to laminin | ||
| Aortic smooth muscle cells | VitroGel® Hydrogel Matrix | VitroGel® Angiogenesis Assay HC kit | Cell attachment | ||
| Endothelial (human) | VitroGel® Angiogenesis Assay | VitroGel® Angiogenesis Assay HC kit | Cell differentiation | ||
| Endotheliocytes | VitroGel® Angiogenesis Assay | VitroGel® Angiogenesis Assay HC kit | Cell migration | ||
| Microvascular endothelial cells (human) | VitroGel® Angiogenesis Assay | VitroGel® Angiogenesis Assay HC kit | Cell mobility | ||
| Aortic endothelial cells (bovine) | VitroGel® Angiogenesis Assay | VitroGel® Angiogenesis Assay HC kit | Force dependent cell spreading | ||
| Capillary endothelial cells (bovine) | VitroGel® Angiogenesis Assay | VitroGel® Angiogenesis Assay HC kit | Capillary like network formation |

Figure 1. Rheological properties of VitroGel® MMP with RPMI medium.
A) The gel formation curve after mixing with RPMI medium. VitroGel MMP was diluted at 1:1 and 1:3 (v/v) with VitroGel Dilution Solution (Type 1) and then mixed with RPMI at a 4:1 (v/v) ratio; B) The gel strength after 24 hours of incubation. The hydrogel was prepared according to the user handbook at 1:0, 1:1, and 1:3 dilution ratios, and incubated at 37°C CO2 for 24 hours before the rheological test. (10 ~ 4000 Pa of G’ of regular products at dilutions. Customized high concentration product to reach over 20K Pa)

Figure 2. Degradation of VitroGel® MMP gel with MMP2 enzyme.
A) The hydrogel was prepared without dilution (1:0 dilution) and incubated for 24 hours before adding MMP2 (1 µg/mL) on top of the hydrogel. The plate was incubated in a 5% CO2 incubator at 37°C and was shaken using an orbital shaker at 40 rpm. The hydrogel obtains a heterogeneous consistency after 24 hours, and by day 6, the entire middle section appears degraded. B) The 1:3 diluted hydrogel was prepared with VitroGel Dilution Solution and incubated as a 1:0 diluted hydrogel. The hydrogel appears to have completely dissolved after 6 hours after exposed to the MMP2 enzyme. C). The rheological data show a rapid decline in the elastic modulus of the 1:3 diluted hydrogel over time after adding the MMP2 enzyme. The gel was almost completely degraded by the enzyme after 200 mins. The test result demonstrates that VitroGel MMP undergoes an MMP-sensitive degradation. The higher the dilution of the gel, the faster the degradation process.

Figure 3. 3D culture of glioblastoma cells (SNB 75) in VitroGel® MMP.
Cells were cultured with 1:3 diluted VitroGel MMP according to the user handbook (50% FBS was used to prepare the cell suspension to achieve a hydrogel with a final 10% FBS concentration).
References/Publications
- Sun, W., Xu, W., Xiao, M., Zhang, X., Chen, J., Zhang, J., Yang, L., & Quan Na. (2025). Enhancing exosome stability and delivery with natural polymers to prevent intrauterine adhesions and promote endometrial regeneration: a review. Journal of Nanobiotechnology, 23(1). https://doi.org/10.1186/s12951-025-03603-8
- Sadiasa, A., Werkmeister, J., Gurung, S., & Gargett, C. (2025). Steps towards the clinical application of endometrial and menstrual fluid mesenchymal stem cells for the treatment of gynecological disorders. Taylor & Francis Online; Expert Opinion on Biological Therapy, 1-23. https://doi.org/10.1080/14712598.2025.2465826
- Powell K. Adding depth to cell culture. Science, 356(6333), 96–98. https://doi.org/10.1126/science.356.6333.96


